Literature DB >> 11525701

Prevalence of gastrointestinal symptoms associated with diabetes mellitus: a population-based survey of 15,000 adults.

P Bytzer1, N J Talley, M Leemon, L J Young, M P Jones, M Horowitz.   

Abstract

BACKGROUND: Gastrointestinal symptoms are reportedly common in diabetes, but a causal link is controversial and adequate population control data are lacking.
OBJECTIVE: To determine whether gastrointestinal symptoms are more frequent in persons with diabetes, particularly in those with poor glycemic control.
METHODS: Fifteen thousand adults were mailed a questionnaire (response rate, 60.0%) containing validated questions on the frequency of troublesome gastrointestinal symptoms within the past 3 months, diabetic status, and self-reported glycemic control. The prevalence of 16 symptoms and 5 symptom complexes, reported to occur often or very often, was compared using logistic regression analysis, adjusting for age and sex.
RESULTS: Overall, 8657 eligible subjects responded; 423 (4.9%) reported having diabetes. Most (94.8%) had type 2 diabetes mellitus. Adjusting for age and sex, all 16 symptoms and the 5 symptom complexes were significantly more frequent in subjects with diabetes compared with controls. An increased prevalence rate of symptoms was significantly associated with poorer levels of glycemic control but not with duration of diabetes or type of diabetic treatment.
CONCLUSIONS: Diabetes mellitus is associated with an increased prevalence of upper and lower gastrointestinal symptoms. This effect may be linked to poor glycemic control but not to duration of diabetes or type of treatment.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11525701     DOI: 10.1001/archinte.161.16.1989

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  189 in total

Review 1.  Origins of Western diseases.

Authors:  Mj Quinn
Journal:  J R Soc Med       Date:  2011-11       Impact factor: 5.344

2.  Diabetes-related alterations in the enteric nervous system and its microenvironment.

Authors:  Mária Bagyánszki; Nikolett Bódi
Journal:  World J Diabetes       Date:  2012-05-15

3.  Laparoscopic pyloroplasty is a safe and effective first-line surgical therapy for refractory gastroparesis.

Authors:  Amber L Shada; Christy M Dunst; Radu Pescarus; Emily A Speer; Maria Cassera; Kevin M Reavis; Lee L Swanstrom
Journal:  Surg Endosc       Date:  2015-08-21       Impact factor: 4.584

Review 4.  Which Patient-Related Factors Determine Optimal Bowel Preparation?

Authors:  Myriam Martel; Charles Ménard; Sophie Restellini; Omar Kherad; Majid Almadi; Maïté Bouchard; Alan N Barkun
Journal:  Curr Treat Options Gastroenterol       Date:  2018-12

5.  Prolonged high fat diet ingestion, obesity, and type 2 diabetes symptoms correlate with phenotypic plasticity in myenteric neurons and nerve damage in the mouse duodenum.

Authors:  Chloe M Stenkamp-Strahm; Yvonne E A Nyavor; Adam J Kappmeyer; Sarah Horton; Martin Gericke; Onesmo B Balemba
Journal:  Cell Tissue Res       Date:  2015-02-28       Impact factor: 5.249

Review 6.  Human pancreatic exocrine response to nutrients in health and disease.

Authors:  J Keller; P Layer
Journal:  Gut       Date:  2005-07       Impact factor: 23.059

Review 7.  An update on autonomic neuropathy affecting the gastrointestinal tract.

Authors:  Liza K Phillips; Christopher K Rayner; Karen L Jones; Michael Horowitz
Journal:  Curr Diab Rep       Date:  2006-12       Impact factor: 4.810

Review 8.  Gastroparesis: Medical and Therapeutic Advances.

Authors:  Christopher M Navas; Nihal K Patel; Brian E Lacy
Journal:  Dig Dis Sci       Date:  2017-07-18       Impact factor: 3.199

Review 9.  Gastrointestinal disturbances in diabetes.

Authors:  Manju Chandran; Neelima V Chu; Steven V Edelman
Journal:  Curr Diab Rep       Date:  2003-02       Impact factor: 4.810

10.  Effects of insulin treatment on HuC/HuD, NADH diaphorase, and nNOS-positive myoenteric neurons of the duodenum of adult rats with acute diabetes.

Authors:  Sônia Trannin de Mello; Marcílio Hubner de Miranda Neto; Jacqueline Nelisis Zanoni; Maria Montserrat D P Furlan
Journal:  Dig Dis Sci       Date:  2008-07-26       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.